Bangalore,
11th June 2026 : Group Pharmaceuticals, a trusted name in the
oral healthcare industry with over 45 years of expertise, recently announced
the launch of Abledent in Bangalore. The
launch event brought together healthcare professionals, caregivers, and
industry stakeholders, underscoring the urgent need for more inclusive and
patient-centric oral care solutions in India.
In
India, the need for assisted daily care, including oral hygiene, is rapidly
growing across age groups. While 1 in every 20 elderly individuals live with
some form of disability and nearly 40% of those aged 60+ face functional or
health-related limitations, children and adults with disabilities,
neurodivergent individuals, and those with special healthcare needs along with
the caregivers who support them continue to face significant barriers to safe
and accessible oral care. Despite this growing need, access to specialised and
user-friendly oral care solutions tailored for assisted care remains limited in
the country. Abledent has been developed with a clear purpose: to make daily
oral hygiene safer, simpler, and more accessible for children and adults with
disabilities, neurodivergent individuals, the elderly, hospitalised patients,
individuals with temporary or permanent mobility challenges, and those
dependent on caregivers.
Developed
through extensive clinical insight and real-world research by Group
Pharmaceuticals, Abledent offers safe if swallowed, non-foaming toothpastes for
those unable to rinse or spit; fluoride-free and remineralising formulations
for sensitive and medically vulnerable users; mouthwashes for enhanced enamel
protection; and no-rinse oral care wipes for hospitalised and dependent care
settings. The range also features inclusive packaging such as easy-open caps
and braille and is built to overcome practical challenges including gag reflex,
sensory sensitivities, mobility limitations, and caregiver-assisted routines -
gaps long ignored by conventional oral care.
Speaking
about the launch, Mr. Nikhil Kaushik, CEO- Group Pharmaceuticals said,
“Healthy smiles are a birthright-not a privilege. With Abledent, we are
addressing a critical gap in oral care by creating solutions that are not only
clinically relevant but also empathetic to the real-world challenges faced by
individuals with disabilities, children with special needs, patients and
caregivers. For far too long, people with special oral care needs have had to
adapt to products that were never designed for them. Abledent changes that by
putting their dignity, comfort, and independence at the center of innovation.”
India’s
oral care market has long overlooked the needs of dependent and special-care
populations. The initiative is further strengthened by the Able Smile Community, an
effort to build awareness, share resources, and create a supportive ecosystem
for caregivers and individuals navigating assisted oral care. With this launch,
Group Pharmaceuticals aims to introduce a new category of oral care in India,
and spark greater awareness and conversation around inclusive healthcare, where
accessibility and dignity are built into everyday solutions.
About
Abledent
Guided
by its philosophy, ‘Enabling Healthy Smiles for Everyone,’ Abledent is an
inclusive oral care range by Group Pharmaceuticals designed for individuals
with assisted and adaptive oral hygiene needs. Built on the promise of ‘More
Easy. More Effective. More Able.’, the range combines clinical innovation with
real-world usability to deliver safer, simpler, and more accessible oral care
solutions for people across different life stages and health conditions.
About
Group Pharmaceuticals Ltd
Founded
in 1980 and is one of India’s leading oral care companies, driven by the belief
that Healthy Smiles Matter. The company is widely recognised for launching many
pioneering oral care products in India, including Potassium Nitrate Toothpaste
Bioactive glass Technologies. Its brands Shy NM, Omnident, Pediflor, Elsenz
among others are trusted by dental professionals and consumers. Its
research-led innovations are developed in collaboration with globally reputed
institutions including Queen Mary University of London, Columbia University,
and JSS Academy of Higher Education & Research. Through science-backed
innovation and a strong commitment to preventive oral healthcare, Group
Pharmaceuticals continues to strengthen its position as a trusted name in India’s
oral care landscape.